DOG & CATS
Mirataz (mirtazapine transdermal ointment) for Cats, 5-g tube
SKU: DECHRA
- Indicated for body weight gain in cats with a history of weight loss
- Helps manage weight loss
- Contains mirtazapine
- Transdermal ointment formulation
- Supports appetite stimulation and weight gain
Weight loss in cats may be an indicator of something more serious. Changes in your cat's appetite, and accompanying weight loss, can be early indicators or underlying diseases such as thyroid, kidney and inflammatory bowel disease. Mirataz (mirtazapine transdermal ointment) is the first and only FDA-approved transdermal medication for the management of weight loss in cats, and can help your cat gain weight. Mirataz is a transdermal ointment applied to the inside of your cat's ear. See your veterinarian if you notice symptoms of weight or appetite loss.We directly source prescription medications from manufacturers and wholesale distributors registered with the FDA and licensed by applicable state boards. Guaranteed genuine, and where applicable, backed by the manufacturer.
Specifications
| Item Number | 179602 |
|---|---|
| Generic Name | Miratazapine |
| Common Brand Name(s) | Mirataz, Remeron |
| For Use With | Cats |
| Administration Form | Otic |
| Product Form | Ointment |
| Drug Type | Antiemetic, Hormone |
Uses
Mirataz (mirtazapine transdermal ointment) is the first and only FDA-approved transdermal medication for the management of weight loss in cats.
Possible Side Effects
The most common adverse reactions included application site reactions, behavioral abnormalities (vocalization and hyperactivity), and vomiting.
Precautions
Do not administer orally or to the eye. Use with caution in cats with hepatic disease. Miratazapine may cause elevated liver enzymes. Use with caution in cats with kidney disease. Kidney diseasemay cause reduced clearance of mirtazapine which may result in higher drug exposure. Upon discontinuation of Mirataz, it is important to montior the cat's food intake. Food intake may lessen after discontinuation of mirtazapine transdermal ointment. If food intake diminishes dramatically (>75%) for several days or if the cat stops eating for more than 48 hours, reevaluate the cat. Mirataz has not been evaluated in cats <2kg or less than 6 months of age. The safe use of MIrataz has not been evaluated in cats that are intended for breeding, pregnant, or lactating cats.
Comments and ratings: Mirataz (mirtazapine transdermal ointment) for Cats, 5-g tube
0